| abstract |
The present invention relates to the new application of FG-4592 and medicines and health care products. The new use is the use of FG-4592 or a pharmaceutically acceptable salt thereof in the preparation of products for the treatment and/or prevention of nerve injury diseases or neurodegenerative diseases. The product can be medicine and/or health product. It overcomes the limitations of the current application of FG-4592 for the treatment of anemia. The FG-4592 can significantly improve the spatial memory function of APP/PS1 transgenic mice and improve the decline of its cognitive function, and can be used for the treatment of Early cognitive impairment, stroke, Alzheimer's disease, cognitive impairment, vascular dementia, Parkinson's disease, etc. |